Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development	$ 15,187	$ 6,865	$ 30,829	$ 12,627
General and administrative	3,965	4,123	8,098	7,984
Total operating expenses	19,152	10,988	38,927	20,611
Operating loss	(19,152)	(10,988)	(38,927)	(20,611)
Other income (expense), net:
Interest and investment income, net	1,314	1,600	2,995	2,628
Interest expense	0	(652)	0	(1,491)
Other income, net	176	43	1,292	2,578
Total other income, net	1,490	991	4,287	3,715
Net loss	$ (17,662)	$ (9,997)	$ (34,640)	$ (16,896)
Net loss per share of common stock-basic	$ (1.44)	$ (0.9)	$ (2.83)	$ (1.75)
Net loss per share of common stock-diluted	$ (1.44)	$ (0.9)	$ (2.83)	$ (1.75)
Weighted average number of common shares outstanding, basic	12,240,443	11,053,241	12,221,373	9,681,875
Weighted average number of common shares outstanding, diluted	12,240,443	11,053,241	12,221,373	9,681,875
Comprehensive loss:
Net Income (Loss)	$ (17,662)	$ (9,997)	$ (34,640)	$ (16,896)
Other comprehensive loss:
Change in unrealized loss on marketable debt securities	(16)	(59)	(74)	(387)
Total other comprehensive loss	(16)	(59)	(74)	(387)
Total comprehensive loss	$ (17,678)	$ (10,056)	$ (34,714)	$ (17,283)